Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer Cases-Reference-Cited by-同舟云学术

Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer Cases

Published:2021-01 Issue:1 Volume:111 Page:269-276
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Suda Kenichi,Mitsudomi Tetsuya,Shintani Yasushi,Okami Jiro,Ito Hiroyuki,Ohtsuka Takashi,Toyooka Shinichi,Mori Takeshi,Watanabe Shun-ichi,Asamura Hisao,Chida Masayuki,Date Hiroshi,Endo Shunsuke,Nagayasu Takeshi,Nakanishi Ryoichi,Miyaoka Etsuo,Okumura Meinoshin,Yoshino Ichiro

Funder

The Japan Lung Cancer Society

Japanese Respiratory Society

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference13 articles.

1. Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma;Kosaka;J Thorac Oncol,2009

2. Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma;Takamochi;J Thorac Cardiovasc Surg,2017

3. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials;Yang;Lancet Oncol,2015

4. Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: a retrospective multi-center analysis;Ito;Lung Cancer,2020

5. The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures;He;Transl Lung Cancer Res,2019

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological Features and Survival Outcomes of Resected Lung Adenosquamous Carcinoma: Results From a Nationwide Japanese Registry Data;CLIN LUNG CANCER;2024

2. Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor–Positive Non‐Small Cell Lung Cancer;Cancer Reports;2024-09

3. Clinicopathological Features and Survival Outcomes of Resected Lung Adenosquamous Carcinoma: Results From a Nationwide Japanese Registry Data;Clinical Lung Cancer;2024-09

4. The Overlooked Cornerstone in Precise Medicine: Personalized Postoperative Surveillance Plan for NSCLC;JTO Clinical and Research Reports;2024-08

5. Lymph node metastasis in early invasive lung adenocarcinoma: Prediction model establishment and validation based on genomic profiling and clinicopathologic characteristics;Cancer Medicine;2024-07